🔎 Trials Near Me

Akèy › Ateroskleroz › Nebraska

Etid klinik pou Ateroskleroz nan Nebraska

7 etid pou Ateroskleroz ap chèche patisipan nan sit nan Nebraska.

Vil nan Nebraska

Tèks ofisyèl etid la (Anglè)

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • Bryan Heart, Lincoln
  • University of Nebraska Medical Center, Omaha
  • Primary Clinical Research, Papillion
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

  • GSR Enterprises, Inc., Lincoln
  • Great Plains Health - Nephrology, North Platte
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

Detecting Peripheral Artery Disease With the Pulse

  • University of Nebraska at Omaha Health Science Collaborative, Omaha
Ap rekriteVolontè an sante akeyi
Laj 19 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07226193

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Elkhorn
  • Research Site, Fremont
  • Research Site, Omaha
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT07000357

Oxygen-guided Supervised Exercise Therapy

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Ap rekrite
Tout laj · Tout sèks · Mizajou Jan 13, 2026 · NCT06003855

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

  • Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE, Omaha
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.